文献速递糖尿病

2型糖尿病合并非白蛋白尿性糖尿病肾病患者的预后并非总是较差:合并大血管并发症的影响(JDDM 54)

The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
PubMed 文献 · Diabetes Care · 2020-03-06

本研究纳入2953例2型糖尿病且eGFR≥30 mL/min/1.73 m2的日本患者,随访至2015年。非白蛋白尿性DKD患者的死亡或CVD风险不高于无DKD者(校正HR 1.02,95%CI 0.66-1.60),且eGFR年下降较其他DKD表型更慢。合并大血管并发症可能是非白蛋白尿性DKD预后的主要决定因素。

要点

  • 非白蛋白尿性DKD患者死亡或CVD风险不高于无DKD者,校正HR 1.02(95%CI 0.66-1.60)。
  • 非白蛋白尿性DKD的eGFR年下降速度较其他DKD表型更慢。
  • 非白蛋白尿性DKD合并大血管并发症时预后较差,大血管并发症可能是主要决定因素。

核心结论

  • 非白蛋白尿性DKD的死亡、CVD事件或肾功能下降风险不高于其他DKD表型。
  • 在非白蛋白尿性DKD中,大血管并发症的存在可能是预后的主要决定因素而非肾脏表型。

研究设计与样本

  • 观察性队列研究,纳入2004年登记的2953例日本2型糖尿病且eGFR≥30 mL/min/1.73 m2患者,随访至2015年。
  • 根据基线白蛋白尿(>30 mg/g肌酐)和eGFR降低(<60 mL/min/1.73 m2)分为四种DKD表型:无DKD、白蛋白尿性DKD无eGFR降低、非白蛋白尿性DKD伴eGFR降低、白蛋白尿性DKD伴eGFR降低。
  • 评估死亡、心血管疾病(CVD)和肾功能下降的风险。

主要发现

  • 平均随访9.7年期间,113例死亡,263例发生CVD。
  • 非白蛋白尿性DKD的死亡或CVD风险不高于无DKD(校正HR 1.02,95%CI 0.66-1.60)。
  • 非白蛋白尿性DKD的eGFR年下降较其他DKD表型更慢。
  • 无既往CVD的非白蛋白尿性DKD患者死亡或CVD风险与无既往CVD的无DKD患者相似。
  • 有既往CVD的非白蛋白尿性DKD患者以及其他DKD表型的风险更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Nonalbuminuric diabetic kidney disease (DKD) has become the prevailing phenotype in patients with type 2 diabetes. However, it remains unclear whether its prognosis is poorer than that of other DKD phenotypes. RESEARCH DESIGN AND METHODS: A total of 2,953 Japanese patients with type 2 diabetes and estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2, enrolled in an observational cohort study in 2004, were followed until 2015. On the basis of albuminuria (>30 mg/g creatinine) and reduced eGFR (<60 mL/min/1.73 m2) at baseline, participants were classified into the four DKD phenotypes-no-DKD, albuminuric DKD without reduced eGFR, nonalbuminuric DKD with reduced eGFR, and albuminuric DKD with reduced eGFR-to assess the risks of mortality, cardiovascular disease (CVD), and renal function decline. RESULTS: During the mean follow-up of 9.7 years, 113 patients died and 263 developed CVD. In nonalbuminuric DKD, the risks of death or CVD were not higher than those in no-DKD (adjusted hazard ratio 1.02 [95% CI 0.66, 1.60]) and the annual decline in eGFR was slower than in other DKD phenotypes. The risks of death or CVD in nonalbuminuric DKD without prior CVD were similar to those in no-DKD without prior CVD, whereas the risks in nonalbuminuric DKD with prior CVD as well as other DKD phenotypes were higher. CONCLUSIONS: Nonalbuminuric DKD did not have a higher risk of mortality, CVD events, or renal function decline than the other DKD phenotypes. In nonalbuminuric DKD, the presence of macrovascular complications may be a main determinant of prognosis rather than the renal phenotype.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Yokoyama H, Araki SI, Kawai K, et al. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54). Diabetes Care. 2020. PMID: 32144168. doi:10.2337/dc19-2049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。